Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 147

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 147
---
mation of the Business Combination.

On April 3, 2024, the Business
Combination was consummated with the Company as the surviving entity.

<div align='center'>85</div>

NewGenIvf’s Business

With a focus on providing
fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely: (i) in vitro fertilization
(“IVF”) treatment service, comprising traditional IVF and egg donation; and (ii) surrogacy and ancillary caring services.
Currently, we have three clinics: one clinic in Thailand, one clinic in Cambodia, and one clinic in Kyrgyzstan.

For the years ended December 31,
2024 and 2023, NewGenIvf’s revenue was US$5,433,375 and US$5,136,153, and its net income/(loss) was US$(474,101) and US$108,418,
respectively.

Market Opportunity

According to CIC, NewGenIvf’s
core market for fertility services is substantial and growing rapidly, driven by, among other things, societal and cultural shifts, such
as people starting families later in life and other health-related challenges which could impact couples’ and individuals’
ability to have children. In addition, NewGenIvf believes that continued overall de-stigmatization of infertility will help drive better
access to, and stronger demand for, fertility treatment services, thereby further enabling the expansion of NewGenIvf’s addressable
market. According to CIC, the market size of fertility treatments in Asia Pacific was increasing steadily and the potential size of the
Asia fertility market is expected to reach US$37.4 billion by 2030. NewGenIvf believes its market opportunity is substantial and
is continuing to grow as a result of the rising demand for fertility services, the lack of adequate offerings in the market and the increasing
awareness of the challenges of infertility.

<div align='center'>86</div>

Competitive Strengths

NewGenIvf believes that the
following competitive strengths have positioned it to meet growing opportunities in the fertility market across Asia-Pacific, and have
differentiated it from its competitors:

Broad-range ARS Provider Offering Comprehensive Fertility Treatment Services

With almost a decade of experience
in the fertility market, NewGenIvf has built a reputation in the IVF industry in Asia-Pacific. NewGenIvf has reinforced its long-standing
position through expanding its service offerings